ISRA confirms the revenue and result forecasts

ISRA VISION: The revenue and results are developing well in a friendly business environment as anticipated

(PresseBox) ( Darmstadt, )
ISRA VISION AG (ISIN: DE 0005488100), one of the top five suppliers of industrial image processing (Machine Vision) globally and the world market leader for surface inspection systems confirms its revenue and result forecasts for the closing fiscal year which ends September 30, 2007/2008. In their latest analysis, three famous research companies have recommended to buy ISRA shares. Landesbank Baden-Württemberg, Equinet and Matelan Research have calculated the upside target for the ISRA share of around 20 Euro - based on their forecast model.

At the moment, ISRA is completing the nine-month report. A first overview shows very clearly that business in the past three quarters of the fiscal year 2007/2008 have developed according the already communicated forecasts. Also the positive prospects for the rest of the fiscal year will remain the same. The nine-month report will be published as planned at the end of August.

"Unfortunately, the ISRA share cannot escape the present negative stock market trend. However, the unpleasant stock market trend is in no way linked with the current business development of the company or the forecast about the business expected", explains Enis Ersü, Chairman of the Board of ISRA VISISION AG, the slump of stock exchange value.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to